Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  AGN 194310

AGN 194310

Basic information Safety Supplier Related

AGN 194310 Basic information

Product Name:
AGN 194310
Synonyms:
  • AGN 194310
  • AGN-194310, 194310
  • CS-1211
  • AGN194310; AGN-194310; VTP194310; VTP 194310; VTP-194310
  • VTP 194310
  • VTP194310
  • VTP-194310
  • AGN
CAS:
229961-45-9
MF:
C28H24O2S
MW:
424.55
Mol File:
229961-45-9.mol
More
Less

AGN 194310 Chemical Properties

Boiling point:
598.1±50.0 °C(Predicted)
Density 
1.26±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
>16.8mg/mL in DMSO
form 
Powder
pka
4.02±0.10(Predicted)
color 
White to off-white
InChI
1S/C28H24O2S/c1-4-19-7-12-22(13-8-19)25-18-28(2,3)31-26-16-11-21(17-24(25)26)6-5-20-9-14-23(15-10-20)27(29)30/h7-18H,4H2,1-3H3,(H,29,30)
InChIKey
LHUPKWKWYWOMSK-UHFFFAOYSA-N
SMILES
O=C(O)C1=CC=C(C#CC2=CC3=C(SC(C)(C=C3C4=CC=C(CC)C=C4)C)C=C2)C=C1
More
Less

Safety Information

WGK Germany 
WGK 3
Storage Class
11 - Combustible Solids
More
Less

AGN 194310 Usage And Synthesis

Uses

AGN 194310 (VTP-194310) is a high affinity, potent and selective retinioic acid receptors (RARs) pan-antagonist with Kd values of 3 nM, 2 nM, 5 nM for RARα, RARβ, RARγ, respectively[1][2]. AGN 194310 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Biological Activity

AGN 194310 (VTP-194310) is a high-affinity, potent, and selective pan-antagonist of retinoic acid receptors (RARs) with Kd values of 3 nM and 2 nM for RARα, RARβ, and RARγ, respectively , 5 nM.

in vivo

AGN 194310 (0.5 mg/kg/day; oral gavage; every day; for 10 days; female C57Bl/6J mice) treatment increases the number of granulocytes across haemopoietic compartments. A significant increase in the frequency of granulocyte -progenitor cells are observed in the bone marrow of mice after treatment with AGN194310.

Animal Model: Female C57Bl/6J mice (Five -week-old (34-37 days))
Dosage: 0.5 mg/kg/ day
Administration: Oral gavage; every day; for 10 days
Result: The number of granulocytes was significantly increased across haemopoietic compartments. Progenitor cells containing granulocytes also increased significantly.

target

< /table>

References

[1] Johnson AT, et al. Synthesis and biological activity of high-affinity retinoic acid receptor antagonists. Bioorg Med Chem. 1999 Jul;7(7):1321-38. DOI:10.1016/s0968-0896(99)00055-3
[2] Hammond LA, et al. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells. Br J Cancer. 2001 Aug 3;85(3):453-62. DOI:10.1054/bjoc.2001.1939
[3] Walkley CR, et al. Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis. Leukemia. 2002 Sep;16(9):1763-72. DOI:10.1038/sj.leu.2402625

AGN 194310Supplier

BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Email
sales@letopharm.com
SPIRO PHARMA
Tel
Email
eric_feng1954@126.com
Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com

RARα

3 nM (Kd)

RARβ

2 nM (Kd)

RARγ

5 nM (Kd)